Open AccessPRIMARY IMMUNOSUPPRESSION WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL FOR RENAL ALLOGRAFT RECIPIENTS1
Author(s) -
David Roth,
J. Colona,
George W. Burke,
Gaetano Ciancio,
Violet Esquenazi,
Joshua Miller
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199801270-00018
Subject(s) - medicine , tacrolimus , leukopenia , discontinuation , immunosuppression , mycophenolic acid , mycophenolate , gastroenterology , surgery , transplantation , chemotherapy
Studies using tacrolimus and corticosteroids or the combination of cyclosporine, mycophenolate mofetil, and corticosteroids have been shown to reduce the incidence of biopsy-proven acute rejection episodes in cadaveric kidney recipients compared with cyclosporine-based immunosuppression. The current study is a retrospective analysis of our experience with tacrolimus combined with mycophenolate mofetil and steroids as primary immunosuppression for kidney transplant recipients.